,docid,label_s,uri_s
0,3165515,"E. Meriglier, C. Rivoisy, Mojgan Hessamfar, N. Bernard, I. Aureau, et al.. Safety of hydroxychloroquine and darunavir or lopinavir in COVID-19 infection. Journal of Antimicrobial Chemotherapy, Oxford University Press (OUP), 2021, 76 (2), pp.482-486. &#x27E8;10.1093/jac/dkaa441&#x27E9;. &#x27E8;hal-03165515&#x27E9;",https://hal.archives-ouvertes.fr/hal-03165515
1,3127508,"Thibault Fiolet, Anthony Guihur, Mathieu Edouard Rebeaud, Matthieu Mulot, Nathan Peiffer-Smadja, et al.. Effect of hydroxychloroquine with or without azithromycin on the mortality of coronavirus disease 2019 (COVID-19) patients: a systematic review and meta-analysis. Clinical Microbiology and Infection, Elsevier for the European Society of Clinical Microbiology and Infectious Diseases, 2021, 27 (1), pp.19-27. &#x27E8;10.1016/j.cmi.2020.08.022&#x27E9;. &#x27E8;hal-03127508&#x27E9;",https://hal.archives-ouvertes.fr/hal-03127508
2,2130728,"Federico Perche, Y. Yi, L. Hespel, P Mi, A Dirisala, et al.. Hydroxychloroquine-conjugated gold nanoparticles for improved siRNA activity. Biomaterials, Elsevier, 2016, 90, pp.62-71. &#x27E8;10.1016/j.biomaterials.2016.02.027&#x27E9;. &#x27E8;hal-02130728&#x27E9;",https://hal.archives-ouvertes.fr/hal-02130728
3,1243546,Maryse Lepoittevin. Intérêt comparé de l’imagerie et de l’électrorétinographie multifocale dans le suivi des patients traités par Chloroquine ou Hydroxychloroquine. Médecine humaine et pathologie. 2015. &#x27E8;dumas-01243546&#x27E9;,https://dumas.ccsd.cnrs.fr/dumas-01243546
4,3337966,"M. Cour, C. Amaz, J. Bohe, T. Rimmele, M. Ovize, et al.. Day-90 survival in critically-ill patients with COVID-19 and hydroxychloroquine: a propensity analysis. Annals of translational medicine, AME Publishing Company, 2021, 9 (7), pp.524. &#x27E8;10.21037/atm-20-7811&#x27E9;. &#x27E8;inserm-03337966&#x27E9;",https://www.hal.inserm.fr/inserm-03337966
5,3014830,"Guillaume Binson, Nicolas Venisse, Alexis Sauvaget, Astrid Bacle, Pauline Lazaro, et al.. Preparation and physicochemical stability of 50 mg/mL hydroxychloroquine oral suspension in SyrSpend(Ⓡ) SF PH4 (dry). International Journal of Antimicrobial Agents, Elsevier, 2020, 56 (6), pp.106201. &#x27E8;10.1016/j.ijantimicag.2020.106201&#x27E9;. &#x27E8;hal-03003546&#x27E9;",https://hal.archives-ouvertes.fr/hal-03003546
6,3330961,"J Weber, M Alt, G Blaison, M Welsch, T Martin, et al.. Modifications du goût et de l'odorat imputables à l'hydroxychloroquine. La Presse Médicale, Elsevier Masson, 1996, 25 (5), pp.213. &#x27E8;hal-03330961&#x27E9;",https://hal.archives-ouvertes.fr/hal-03330961
7,1573748,"Emmanouil Angelakis, Jacques Bou Khalil, Marion Le Bideau, Celine Perreal, Bernard La Scola, et al.. Hydroxychloroquine susceptibility determination of Coxiella burnetii in human embryonic lung (HEL) fibroblast cells. International Journal of Antimicrobial Agents, Elsevier, 2017, 50 (1), pp.106-109. &#x27E8;10.1016/j.ijantimicag.2017.02.015&#x27E9;. &#x27E8;hal-01573748&#x27E9;",https://hal.archives-ouvertes.fr/hal-01573748
8,3146336,"Ai-Ling Tian, Qi Wu, Peng Liu, Liwei Zhao, Isabelle Martins, et al.. Lysosomotropic agents including azithromycin, chloroquine and hydroxychloroquine activate the integrated stress response. Cell Death and Disease, Nature Publishing Group, 2021, 12 (1), &#x27E8;10.1038/s41419-020-03324-w&#x27E9;. &#x27E8;hal-03146336&#x27E9;",https://hal.sorbonne-universite.fr/hal-03146336
9,3141834,"M. Roustit, R. Guilhaumou, Mathieu Molimard, M. D. Drici, S. Laporte, et al.. Chloroquine and hydroxychloroquine in the management of COVID-19: Much kerfuffle but little evidence. Thérapie, EDP Sciences, In press, 75 (4), pp.363-370. &#x27E8;10.1016/j.therap.2020.05.010&#x27E9;. &#x27E8;hal-03141834&#x27E9;",https://hal.archives-ouvertes.fr/hal-03141834
10,2336998,"Clotilde Chatre, François Roubille, Hélène Vernhet, Christian Jorgensen, Yves-Marie Pers. Cardiac Complications Attributed to Chloroquine and Hydroxychloroquine: A Systematic Review of the Literature. Drug Safety, Springer Verlag, 2018, 41 (10), pp.919--931. &#x27E8;10.1007/s40264-018-0689-4&#x27E9;. &#x27E8;hal-02336998&#x27E9;",https://hal.archives-ouvertes.fr/hal-02336998
11,3231601,Hervé Seitz. Hydroxychloroquine et Covid-19 : résumé d'un an de controverse. 2021. &#x27E8;hal-03231601&#x27E9;,https://hal.archives-ouvertes.fr/hal-03231601
12,3338004,"Yves-Marie Pers, Guillaume Padern. Revisiting the cardiovascular risk of hydroxychloroquine in RA. Nature Reviews Rheumatology, Nature Publishing Group, 2020, 16 (12), pp.671-672. &#x27E8;10.1038/s41584-020-00521-x&#x27E9;. &#x27E8;hal-03338004&#x27E9;",https://hal.umontpellier.fr/hal-03338004
13,3124849,"David Demortain, Pierre Benoit Joly. Urgence thérapeutique, controverses et production de la preuve dans l'espace public. A propos de l'hydroxychloroquine. AOC [Analyse Opinion Critique], société AOC, 2020, 4 p. &#x27E8;hal-03124849&#x27E9;",https://hal.archives-ouvertes.fr/hal-03124849
14,2935265,"Marie Lecronier, Alexandra Beurton, Sonia Burrel, Luc Haudebourg, Robin Deleris, et al.. Comparison of hydroxychloroquine, lopinavir/ritonavir, and standard of care in critically ill patients with SARS-CoV-2 pneumonia: an opportunistic retrospective analysis. Critical Care, BioMed Central, 2020, 24 (1), pp.418. &#x27E8;10.1186/s13054-020-03117-9&#x27E9;. &#x27E8;hal-02935265&#x27E9;",https://hal.sorbonne-universite.fr/hal-02935265
15,3155464,"Alexandre Lopez, Gary Duclos, Bruno Pastène, Karine Bézulier, Romain Guilhaumou, et al.. Effects of Hydroxychloroquine on Covid-19 in Intensive Care Unit Patients: Preliminary Results. International Journal of Antimicrobial Agents, Elsevier, 2020, 56 (5), pp.106136. &#x27E8;10.1016/j.ijantimicag.2020.106136&#x27E9;. &#x27E8;hal-03155464&#x27E9;",https://hal.inrae.fr/hal-03155464
16,1859742,"Clea Melenotte, Didier Raoult. Pro-apoptotic effect of doxycycline and hydroxychloroquine on B-cell lymphoma induced by C. burnetii. Oncotarget, Impact journals, 2018, 9 (2), pp.2726-2727. &#x27E8;10.18632/oncotarget.23397&#x27E9;. &#x27E8;hal-01791638&#x27E9;",https://hal.archives-ouvertes.fr/hal-01791638
17,3093028,"Riaz Khan, Vincent Aroulmoji. Hyaluronic Acid - Hydroxychloroquine Conjugate Proposed for Treatment of COVID-19. International journal of advanced Science and Engineering, Mahendra Publications, 2020, 06, pp.1469 - 1471. &#x27E8;10.29294/ijase.6.4.2020.1469-1471&#x27E9;. &#x27E8;hal-03093028&#x27E9;",https://hal.archives-ouvertes.fr/hal-03093028
18,585174,"Richard Bergholz, Jan Schroeter, Klaus Ruether. Evaluation of risk factors for retinal damage due to chloroquine and hydroxychloroquine. British Journal of Ophthalmology, BMJ Publishing Group, 2010, 94 (12), pp.1637. &#x27E8;10.1136/bjo.2009.174458&#x27E9;. &#x27E8;hal-00585174&#x27E9;",https://hal.archives-ouvertes.fr/hal-00585174
19,3098704,"Vincent Fleury. Comment on ""Early Outpatient Treatment of Symptomatic, High-Risk Covid-19 Patients That Should be Ramped-Up Immediately as Key to the Pandemic Crisis"". American Journal of Epidemiology, Oxford University Press (OUP), 2020. &#x27E8;hal-03098704&#x27E9;",https://hal.archives-ouvertes.fr/hal-03098704
20,3149262,"Y. Roussel, D. Raoult. Influence of conflicts of interest on public positions in the COVID-19 era, the case of Gilead Sciences. NEW MICROBES AND NEW INFECTIONS, 2020, 38, &#x27E8;10.1016/j.nmni.2020.100710&#x27E9;. &#x27E8;hal-03149262&#x27E9;",https://hal-amu.archives-ouvertes.fr/hal-03149262
21,3335720,"Michel Drancourt, Sébastien Cortaredona, Cléa Melenotte, Sophie Amrane, Carole Eldin, et al.. SARS-CoV-2 Persistent Viral Shedding in the Context of Hydroxychloroquine-Azithromycin Treatment. Viruses, MDPI, 2021, 13 (5), pp.890. &#x27E8;10.3390/v13050890&#x27E9;. &#x27E8;hal-03304410&#x27E9;",https://hal-amu.archives-ouvertes.fr/hal-03304410
22,1150855,Arnaud Mazouyes. Efficacité de la triple association Méthotrexate Sulfasalazine et Hydroxychloroquine dans la polyarthrite récente ayant une réponse insuffisante au Méthotrexate : méta-analyse d'essais contrôlés randomisés. Médecine humaine et pathologie. 2015. &#x27E8;dumas-01150855&#x27E9;,https://dumas.ccsd.cnrs.fr/dumas-01150855
23,3339719,"Vincent Dubée, Pierre-Marie Roy, Bruno Vielle, Elsa Parot-Schinkel, Odile Blanchet, et al.. Hydroxychloroquine in mild-to-moderate coronavirus disease 2019: a placebo-controlled double blind trial. Clinical Microbiology and Infection, Elsevier for the European Society of Clinical Microbiology and Infectious Diseases, 2020, 27, pp.1124 - 1130. &#x27E8;10.1016/j.cmi.2021.03.005&#x27E9;. &#x27E8;inserm-03339719&#x27E9;",https://www.hal.inserm.fr/inserm-03339719
24,1524470,"François Chasset. Intérêt de l’augmentation du taux sanguin d’hydroxychloroquine dans le lupus cutané réfractaire à ce traitement : un essai prospectif en ouvert sur 34 patients
. Médecine humaine et pathologie. 2016. &#x27E8;dumas-01524470&#x27E9;",https://dumas.ccsd.cnrs.fr/dumas-01524470
25,3373200,"David Lebeaux, Matthieu Revest. No evidence of clinical benefits of early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: Comment on &quot;Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France&quot;. Travel Medicine and Infectious Disease, Elsevier, 2020, 36, pp.101819. &#x27E8;10.1016/j.tmaid.2020.101819&#x27E9;. &#x27E8;hal-03373200&#x27E9;",https://hal.archives-ouvertes.fr/hal-03373200
26,1585044,"S Jaumouillé, D Espargillière, F Mouriaux, B Mortemousque.  Clinical evaluation of the new screening procedures for hydroxychloroquine retinopathy, according to the American Academy of Ophthalmology guidelines. . Journal Français D'Ophtalmologie, Elsevier Masson, 2015, 38 (5), pp.377-87. &#x27E8;10.1016/j.jfo.2015.01.005&#x27E9;. &#x27E8;hal-01585044&#x27E9;",https://hal.archives-ouvertes.fr/hal-01585044
27,3032430,"Corrado Mascia, Veronica Paparozzi, Angelica Ragni, Elisa Scanu, Chiara Simeoni, et al.. COVID-19 Calls for Mathematics, Part 1: Neuraminidase Inhibitors, Chloroquine and Hydroxychloroquine. Organisms. Journal of Biological Sciences, Sapienza University of Rome, 2020, 4 (1), pp.115-127. &#x27E8;10.13133/2532-5876/16968&#x27E9;. &#x27E8;hal-03032430&#x27E9;",https://hal.archives-ouvertes.fr/hal-03032430
28,3134407,"S. Ducassou, A. Gourdonneau, H. Fernandes, G. Leverger, M. Pasquet, et al.. Second-line treatment trends and long-term outcomes of 392 children with chronic immune thrombocytopenic purpura: the French experience over the past 25 years. British Journal of Haematology, Wiley, In press, 189 (5), pp.931-942. &#x27E8;10.1111/bjh.16448&#x27E9;. &#x27E8;hal-03134407&#x27E9;",https://hal.archives-ouvertes.fr/hal-03134407
29,3111881,"Rajnish Kumar, Anju Sharma, Janmejai Kumar Srivastava, Mohammed Haris Siddiqui, Md. Sahab Uddin, et al.. Hydroxychloroquine in COVID-19: therapeutic promises, current status, and environmental implications. Environmental Science and Pollution Research, Springer Verlag, 2021, &#x27E8;10.1007/s11356-020-12200-1&#x27E9;. &#x27E8;hal-03111881&#x27E9;",https://hal.archives-ouvertes.fr/hal-03111881
30,3373197,"Francois Benezit, Audrey Le Bot, Stéphane Jouneau, Florian Lemaitre, Charlotte Pronier, et al.. COVID-19 in Patient with Sarcoidosis Receiving Long-Term Hydroxychloroquine Treatment, France, 2020. Emerging Infectious Diseases, Centers for Disease Control and Prevention, 2020, 26 (10), pp.2513-2515. &#x27E8;10.3201/eid2610.201816&#x27E9;. &#x27E8;hal-03373197&#x27E9;",https://hal.archives-ouvertes.fr/hal-03373197
31,3092803,"Luc Berlivet, Ilana Löwy. Hydroxychloroquine Controversies: Clinical Trials, Epistemology, and the Democratization of Science. Medical Anthropology Quarterly, American Anthropological Association, 2020, 34 (4), pp.525-541. &#x27E8;10.1111/maq.12622&#x27E9;. &#x27E8;hal-03092803&#x27E9;",https://hal.archives-ouvertes.fr/hal-03092803
32,3268751,"I. Moulonguet, P. Braun-Arduz, F. Plantier, Nicolas Lerolle, Audrey Petit. Panniculite lipoatrophiante de l’adulte : traitement par hydroxychloroquine. Annales de Dermatologie et de Vénéréologie, Elsevier Masson, 2011, 138 (10), pp.681 - 685. &#x27E8;10.1016/j.annder.2011.05.017&#x27E9;. &#x27E8;hal-03268751&#x27E9;",https://hal.univ-angers.fr/hal-03268751
33,3335240,"Romain Lutaud, Dimiti Scronias, Jeremy Ward, Pierre Verger. The hydroxychloroquine debate: a therapeutic dilemma for general practitioners. European Journal of Public Health, Oxford University Press (OUP): Policy B - Oxford Open Option D, 2021, 31 (2), pp.283-285. &#x27E8;10.1093/eurpub/ckab002&#x27E9;. &#x27E8;hal-03334318&#x27E9;",https://hal-amu.archives-ouvertes.fr/hal-03334318
34,3284513,"Eric Espinosa, Salvatore Valitutti, Michel Laroche, Camille Laurent, Pol‐andré Apoil, et al.. Hydroxychloroquine as a novel therapeutic approach in mast cell activation diseases. Clinical Immunology, Elsevier, 2018, 194, pp.75-79. &#x27E8;10.1016/j.clim.2018.07.004&#x27E9;. &#x27E8;hal-03284513&#x27E9;",https://hal-univ-tlse3.archives-ouvertes.fr/hal-03284513
35,2301417,"F. Perche, Y. Yi, L. Hespel, P. Mi, A. Dirisala, et al.. Hydroxychloroquine-conjugated gold nanoparticles for improved siRNA activity. Biomaterials, Elsevier, 2016, 90, pp.62-71. &#x27E8;10.1016/j.biomaterials.2016.02.027&#x27E9;. &#x27E8;hal-02301417&#x27E9;",https://hal.archives-ouvertes.fr/hal-02301417
36,1477005,"M Leroux, Cyrille Desveaux, M Parcevaux, B Juliac, Jean-Bernard Gouyon, et al.. Impact of hydroxychloroquine on preterm delivery and intrauterine growth restriction in pregnant women with systemic lupus erythematosus: a descriptive cohort study. Lupus, SAGE Publications, 2015, 24 (13), pp.1384--1391. &#x27E8;10.1177/0961203315591027&#x27E9;. &#x27E8;hal-01477005&#x27E9;",https://hal.univ-reunion.fr/hal-01477005
37,3048120,"Renáta Varga. « La polémique Raoult » : brouillage de la communication. Revue de Recherches Francophones en Sciences de l'Information et de la Communication, Revue REFSICOM, 2020, Communication de crise, médias et gestion des risques du Covid-19, 2020 (9). &#x27E8;hal-03048120&#x27E9;",https://hal.archives-ouvertes.fr/hal-03048120
38,3356478,"Claire Rempenault, Bernard Combe, Thomas Barnetche, Cécile Gaujoux-Viala, Cédric Lukas, et al.. Clinical and Structural Efficacy of Hydroxychloroquine in Rheumatoid Arthritis: A Systematic Review. Arthritis Care & Research = Arthritis Care and Research, Wiley-Blackwell, 2019, 72 (1), pp.36-40. &#x27E8;10.1002/acr.23826&#x27E9;. &#x27E8;hal-03356478&#x27E9;",https://hal.umontpellier.fr/hal-03356478
39,3150830,"Clara Locher, David Moher, Ioana A Cristea, Florian Naudet. Publication by association: the Covid-19 pandemic reveals relationships between authors and editors. 2020. &#x27E8;hal-03150830&#x27E9;",https://hal-univ-rennes1.archives-ouvertes.fr/hal-03150830
40,2927316,"Alexandre Malmartel, Adeline Marie Christine Jouannin, Denis Pouchain. Combination of hydroxychloroquine and azithromycin as a treatment of Covid-19. Results of an observational study including 80 Covid-19 patients. Exercer, 2020, pp.221-223. &#x27E8;hal-02927316&#x27E9;",https://hal.archives-ouvertes.fr/hal-02927316
41,1939363,"Denis Vincent, Denise Ponard, Sandrine Fiorella, Christian Drouet. Benefits of hydroxychloroquine in the treatment of a patient with angioedema due to acquired C1 inhibitor deficiency. Annals of Allergy, Asthma and Immunology, Elsevier, 2015, 114 (1), pp.68-70. &#x27E8;10.1016/j.anai.2014.10.008&#x27E9;. &#x27E8;hal-01939363&#x27E9;",https://hal.umontpellier.fr/hal-01939363
42,3092584,Pierre-Henri Castel. Hydroxychloroquine : quelle(s) controverse(s) ?. 2020. &#x27E8;hal-03092584&#x27E9;,https://hal.archives-ouvertes.fr/hal-03092584
43,3177247,"Noël Zahr, Saik Urien, Christian Funck-Brentano, Hélène Vantomme, Nicolas Garcelon, et al.. Evaluation of Hydroxychloroquine Blood Concentrations and Effects in Childhood-Onset Systemic Lupus Erythematosus. Pharmaceuticals, MDPI, 2021, 14 (3), pp.273. &#x27E8;10.3390/ph14030273&#x27E9;. &#x27E8;hal-03177247&#x27E9;",https://hal.sorbonne-universite.fr/hal-03177247
44,2350944,"Claire Rempenault, Bernard Combe, Thomas Barnetche, Cécile Gaujoux-Viala, Cédric Lukas, et al.. Metabolic and cardiovascular benefits of hydroxychloroquine in patients with rheumatoid arthritis: a systematic review and meta-analysis. Annals of the Rheumatic Diseases, BMJ Publishing Group, 2018, 77 (1), pp.98--103. &#x27E8;10.1136/annrheumdis-2017-211836&#x27E9;. &#x27E8;hal-02350944&#x27E9;",https://hal.archives-ouvertes.fr/hal-02350944
45,3139161,"Jacques Fantini, Coralie Scala, Henri Chahinian, Nouara Yahi. Synergistic antiviral effect of hydroxychloroquine and azithromycin in combination against SARS-CoV-2: What molecular dynamics studies of virus-host interactions reveal. International Journal of Antimicrobial Agents, Elsevier, 2020, 56 (2), pp.106020. &#x27E8;10.1016/j.ijantimicag.2020.106020&#x27E9;. &#x27E8;hal-03139161&#x27E9;",https://hal-amu.archives-ouvertes.fr/hal-03139161
46,3157036,"Philippe Giaime, Maxime Guenoun, Nathalie Pedinielli, Hervé Narbonne, Jean-Philippe Bergounioux, et al.. Hydroxychloroquine and azithromycin tolerance in haemodialysis patients during COVID-19 infection. Nephrology Dialysis Transplantation, Oxford University Press (OUP), 2020, 35 (8), pp.1346-1353. &#x27E8;10.1093/ndt/gfaa191&#x27E9;. &#x27E8;hal-03157036&#x27E9;",https://hal.inrae.fr/hal-03157036
47,2180503,"A. Gueniffey, A. Deroux, M. Cheloufi, C. Wackenheim, C. Dumestre-Perard, et al.. Utilisation de l’hydroxychloroquine et de la prednisone en présence d’une auto-immunité sérique dans l’infertilité féminine. Gynécologie Obstétrique Fertilité & Sénologie, Elsevier, 2018, 46 (2), pp.112-117. &#x27E8;10.1016/j.gofs.2017.12.008&#x27E9;. &#x27E8;hal-02180503&#x27E9;",https://hal.archives-ouvertes.fr/hal-02180503
48,1988149,"François Chasset, Laurent Arnaud, Nathalie Costedoat-Chalumeau, Noël Zahr, Didier Bessis, et al.. The effect of increasing the dose of hydroxychloroquine (HCQ) in patients with refractory cutaneous lupus erythematosus (CLE): An open-label prospective pilot study. Journal of The American Academy of Dermatology, Elsevier, 2016, 74 (4), pp.693-699.e3. &#x27E8;10.1016/j.jaad.2015.09.064&#x27E9;. &#x27E8;hal-01988149&#x27E9;",https://hal.umontpellier.fr/hal-01988149
49,3167732,"Guillaume Martin-Blondel, Stéphanie Ruiz, Marlene Murris, Stanilas Faguer, Véronigue Duhalde, et al.. Hydroxychloroquine in Coronavirus Disease 2019 Patients: What Still Needs to Be Known About the Kinetics. Clinical Infectious Diseases, Oxford University Press (OUP), 2020, 71 (11), pp.2962-2964. &#x27E8;10.1093/cid/ciaa558&#x27E9;. &#x27E8;hal-03167732&#x27E9;",https://hal-univ-tlse3.archives-ouvertes.fr/hal-03167732
50,934853,"Moez Jallouli, Camille Francès, Jean-Charles Piette, Du Le Thi Huong, Philippe Moguelet, et al.. Hydroxychloroquine-induced pigmentation in patients with systemic lupus erythematosus: a case-control study.. JAMA Dermatology, American Medical Association, 2013, 149 (8), pp.935-40. &#x27E8;10.1001/jamadermatol.2013.709&#x27E9;. &#x27E8;hal-00934853&#x27E9;",https://hal.univ-brest.fr/hal-00934853
51,2901923,"F. Bessière, H. Roccia, A. Delinière, R. Charriere, P. Chevalier, et al.. Assessment of QT Intervals in a Case Series of Patients With Coronavirus Disease 2019 (COVID-19) Infection Treated With Hydroxychloroquine Alone or in Combination With Azithromycin in an Intensive Care Unit. JAMA Cardiology, American Medical Association 2020, &#x27E8;10.1001/jamacardio.2020.1787&#x27E9;. &#x27E8;hal-02901923&#x27E9;",https://hal.archives-ouvertes.fr/hal-02901923
52,1496163,Paul Billoir. Intérêt du test de génération de thrombine dans le syndrome des antiphospholipides. Sciences pharmaceutiques. 2016. &#x27E8;dumas-01496163&#x27E9;,https://dumas.ccsd.cnrs.fr/dumas-01496163
53,1730958,"Nicholas Armstrong, Magali Richez, Didier Raoult, Eric Chabriere. Simultaneous UHPLC-UV analysis of hydroxychloroquine, minocycline and doxycycline from serum samples for the therapeutic drug monitoring of Q fever and Whipple's disease. Journal of Chromatography B - Analytical Technologies in the Biomedical and Life Sciences, Elsevier, 2017, 1060, pp.166-172. &#x27E8;10.1016/j.jchromb.2017.06.011&#x27E9;. &#x27E8;hal-01730958&#x27E9;",https://hal.archives-ouvertes.fr/hal-01730958
54,2966074,"Jean-Louis Montastruc, Pierre-Louis Toutain. A New Drug–Drug Interaction Between Hydroxychloroquine and Metformin? A Signal Detection Study. Drug Safety, Springer Verlag, 2020, 43 (7), pp.657-660. &#x27E8;10.1007/s40264-020-00955-y&#x27E9;. &#x27E8;hal-02966074&#x27E9;",https://hal.archives-ouvertes.fr/hal-02966074
55,3203708,"R. Thirumalaisamy, V. Aroulmoji, Muhammad Nasir Iqbal, M. Deepa, C. Sivasankar, et al.. Molecular Insights of Hyaluronic Acid-Hydroxychloroquine Conjugate as a Promising Drug in Targeting SARS-CoV-2 Viral Proteins. Journal of Molecular Structure, Elsevier, 2021, pp.130457. &#x27E8;10.1016/j.molstruc.2021.130457&#x27E9;. &#x27E8;hal-03203708&#x27E9;",https://hal.archives-ouvertes.fr/hal-03203708
56,3127690,"M. Lahouati, E. Meriglier, L. Martin, Stéphane Bouchet, A. Desclaux, et al.. COVID-19 infection also occurs in patients taking hydroxychloroquine. Journal of Antimicrobial Chemotherapy, Oxford University Press (OUP), In press, 75 (7), pp.2014-2015. &#x27E8;10.1093/jac/dkaa193&#x27E9;. &#x27E8;hal-03127690&#x27E9;",https://hal.archives-ouvertes.fr/hal-03127690
57,2885976,"Benoit Painvin, Pauline Guillot, Marie-Clemence Verdier, Arnaud Gacouin, Adel Maamar. Hydroxychloroquine pharmacokinetic in COVID-19 critically ill patients: an observational cohort study. Intensive Care Medicine, Springer Verlag, 2020, 46 (9), pp.1772-1773. &#x27E8;10.1007/s00134-020-06142-y&#x27E9;. &#x27E8;hal-02885976&#x27E9;",https://hal.archives-ouvertes.fr/hal-02885976
58,2153408,"Gaëlle Noé, Zahir Amoura, David Combarel, Lesli Lori, Nadine Tissot, et al.. Development and validation of a fast U-HPLC-fluorescent method for the quantification of hydroxychloroquine and its metabolites in patients with lupus.. Therapeutic Drug Monitoring, Lippincott, Williams & Wilkins, 2019, pp.1. &#x27E8;10.1097/FTD.0000000000000614&#x27E9;. &#x27E8;hal-02153408&#x27E9;",https://hal.sorbonne-universite.fr/hal-02153408
59,3127389,"Noel Zahr, Saïk Urien, Benoit Llopis, Valerie Pourcher, Olivier Paccoud, et al.. Pharmacokinetics and pharmacodynamics of hydroxychloroquine in hospitalized patients with COVID-19. Alternative and Complementary Therapies, Mary Ann Liebert, In press, &#x27E8;10.1016/j.therap.2021.01.056&#x27E9;. &#x27E8;hal-03127389&#x27E9;",https://hal.sorbonne-universite.fr/hal-03127389
60,2735132,"Benoit Blanchet, Moez Jallouli, Marie Allard, Pascale Ghillani Dalbin, Lionel Galicier, et al.. Whole blood versus serum hydroxychloroquine levels for drug monitoring of patients with systemic lupus erythematosus : prehole blood versus serum hydroxychloroquine levels for drug monitoring of patients with systemic lupus erythematosus : preliminary results of a pharmacological study.. Annual European Congress of Rheumatology (EULAR), Jun 2019, Madrid, Spain. pp.2, &#x27E8;10.1136/annrheumdis-2019-eular.4215&#x27E9;. &#x27E8;hal-02735132&#x27E9;",https://hal.inrae.fr/hal-02735132
61,3244122,"Guillaume Hache, Jean Marc Rolain, Philippe Gautret, Jean-Claude Deharo, Philippe Brouqui, et al.. Combination of Hydroxychloroquine Plus Azithromycin As Potential Treatment for COVID-19 Patients: Safety Profile, Drug Interactions, and Management of Toxicity. Microbial Drug Resistance, Mary Ann Liebert, 2021, 27 (3), pp.281-290. &#x27E8;10.1089/mdr.2020.0232&#x27E9;. &#x27E8;hal-03243144&#x27E9;",https://hal-amu.archives-ouvertes.fr/hal-03243144
62,2948108,"Christian Funck-Brentano, Lee Nguyen, Joe-Elie Salem. Retraction and republication: cardiac toxicity of hydroxychloroquine in COVID-19. The Lancet, Elsevier, 2020, 396 (10245), pp.e2-e3. &#x27E8;10.1016/S0140-6736(20)31528-2&#x27E9;. &#x27E8;hal-02948108&#x27E9;",https://hal.sorbonne-universite.fr/hal-02948108
63,2948120,"Christian Funck-Brentano, Joe-Elie Salem. Chloroquine or hydroxychloroquine for COVID-19: why might they be hazardous?. The Lancet, Elsevier, 2020, &#x27E8;10.1016/S0140-6736(20)31174-0&#x27E9;. &#x27E8;hal-02948120&#x27E9;",https://hal.sorbonne-universite.fr/hal-02948120
64,2663287,"Clifford Fong, South Australia. Screening potential repurposed COVID-2019 3C-like protease inhibitors. [Research Report] Eigenenergy. 2020. &#x27E8;hal-02663287&#x27E9;",https://hal.archives-ouvertes.fr/hal-02663287
65,3166538,"Anne-Catherine Perroy, Julien Moiroux. Accès aux médicaments et covid-19 : état des lieux. Revue générale de droit médical (RGDM), 2021, Revue générale de droit médical, 29, pp.51-63. &#x27E8;hal-03166538&#x27E9;",https://hal.univ-lille.fr/hal-03166538
66,1807059,"Fanny Babeau, Timothe Busetto, Christian Hamel, Max Villain, Vincent Daien. Adaptive optics: a tool for screening hydroxychloroquine-induced maculopathy?. Acta Ophthalmologica Scandinavica -Supplement-, 2017, 95 (5), pp.e424 - e425. &#x27E8;10.1111/aos.13276&#x27E9;. &#x27E8;hal-01807059&#x27E9;",https://hal.umontpellier.fr/hal-01807059
67,257292,"J.B. Arlet, A. Aouba, F. Suarez, S. Blanche, D. Valeyre, et al.. Efficiency of hydroxychloroquine in the treatment of granulomatous complications in chronic granulomatous disease.. European Journal of Gastroenterology and Hepatology, Lippincott, Williams & Wilkins, 2008, 20, pp.142-144. &#x27E8;hal-00257292&#x27E9;",https://hal.archives-ouvertes.fr/hal-00257292
68,2509381,"Philippe Colson, Jean-Marc Rolain, Jean-Christophe Lagier, Philippe Brouqui, Didier Raoult. Chloroquine and hydroxychloroquine as available weapons to fight COVID-19. International Journal of Antimicrobial Agents, Elsevier, 2020, pp.105932. &#x27E8;10.1016/j.ijantimicag.2020.105932&#x27E9;. &#x27E8;hal-02509381&#x27E9;",https://hal-amu.archives-ouvertes.fr/hal-02509381
69,2564198,"Julien Andreani, Marion Le Bideau, Isabelle Duflot, Priscilla Jardot, Clara Rolland, et al.. In vitro testing of combined hydroxychloroquine and azithromycin on SARS-CoV-2 shows synergistic effect. Microbial Pathogenesis, Elsevier, 2020, 145, pp.104228. &#x27E8;10.1016/j.micpath.2020.104228&#x27E9;. &#x27E8;hal-02564198&#x27E9;",https://hal-amu.archives-ouvertes.fr/hal-02564198
70,3216091,"Matthieu Million, Yanis Roussel, Jean-Christophe Lagier, Didier Raoult. Re: ‘Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients’ by Fiolet et al.. Clinical Microbiology and Infection, Elsevier for the European Society of Clinical Microbiology and Infectious Diseases, 2021, 27 (1), pp.132-133. &#x27E8;10.1016/j.cmi.2020.09.026&#x27E9;. &#x27E8;hal-03216091&#x27E9;",https://hal-amu.archives-ouvertes.fr/hal-03216091
71,3281965,"Christian Devaux, Laurence Camoin-Jau, Jean-Louis Mege, Didier Raoult. Can hydroxychloroquine be protective against COVID-19-associated thrombotic events ?. Journal of Microbiology, Immunology and Infection, Elsevier, 2021, 54 (1), pp.37-45. &#x27E8;10.1016/j.jmii.2020.12.010&#x27E9;. &#x27E8;hal-03281965&#x27E9;",https://hal-amu.archives-ouvertes.fr/hal-03281965
72,3219720,"S. Ruiz, D. Concordet, T. Lanot, B. Georges, P. Goudy, et al.. Hydroxychloroquine lung pharmacokinetics in critically ill patients with COVID-19. International Journal of Antimicrobial Agents, Elsevier, 2021, 57 (2), pp.106247. &#x27E8;10.1016/j.ijantimicag.2020.106247&#x27E9;. &#x27E8;hal-03219720&#x27E9;",https://hal.inrae.fr/hal-03219720
73,3192645,"Caroline Samer, Karine Lacombe, Alexandra Calmy. Cyber harassment of female scientists will not be the new norm. The Lancet Infectious Diseases, New York, NY : Elsevier Science ; The Lancet Pub. Group, 2001-, 2021, 21 (4), pp.457-458. &#x27E8;10.1016/S1473-3099(20)30944-0&#x27E9;. &#x27E8;hal-03192645&#x27E9;",https://hal.sorbonne-universite.fr/hal-03192645
74,646916,"Rosamund Partlett, Euthalia Roussou. The treatment of rheumatoid arthritis during pregnancy. Rheumatology International, Springer Verlag, 2010, 31 (4), pp.445-449. &#x27E8;10.1007/s00296-010-1643-7&#x27E9;. &#x27E8;hal-00646916&#x27E9;",https://hal.archives-ouvertes.fr/hal-00646916
75,1891384,"Charlotte Hua, Claire Rempenault, Bernard Combe. Response to eLetter: ‘Cardiovascular effects of hydroxychloroquine: a systematic review and meta-analysis’ by Mathieu et al. Annals of the Rheumatic Diseases, BMJ Publishing Group, 2018, 77 (10), pp.e66. &#x27E8;10.1136/annrheumdis-2017-212581&#x27E9;. &#x27E8;hal-01891384&#x27E9;",https://hal.archives-ouvertes.fr/hal-01891384
76,1815546,"Ombeline Roche, Nathalie Aladjidi, Josué Rakotonjanahary, Guy Leverger, Thierry Leblanc, et al.. Evaluation of the efficiency of hydroxychloroquine in treating children with immune thrombocytopenia (ITP). American Journal of Hematology, Wiley, 2017, 92 (5), pp.E79 - E81. &#x27E8;10.1002/ajh.24698&#x27E9;. &#x27E8;inserm-01815546&#x27E9;",https://www.hal.inserm.fr/inserm-01815546
77,2995751,"F. Perche, Y. Yi, L. Hespel, P. Mi, A. Dirisala, et al.. Hydroxychloroquine-conjugated gold nanoparticles for improved siRNA activity. Biomaterials, Elsevier, 2016, 90, pp.62-71. &#x27E8;10.1016/j.biomaterials.2016.02.027&#x27E9;. &#x27E8;hal-02995751&#x27E9;",https://hal.archives-ouvertes.fr/hal-02995751
78,1891534,"Charlotte Hua, Claire Rempenault, Bernard Combe. Response to: ‘Metabolic and cardiovascular benefits of hydroxychloroquine: exploration in a wider population at high CV risk’ by Pareek et al. Annals of the Rheumatic Diseases, BMJ Publishing Group, 2017, &#x27E8;10.1136/annrheumdis-2017-212557&#x27E9;. &#x27E8;hal-01891534&#x27E9;",https://hal.archives-ouvertes.fr/hal-01891534
79,3149261,"Y. Roussel, D. Raoult. First evaluation of hydroxychloroquine recommendations in treating SARS-CoV-2. NEW MICROBES AND NEW INFECTIONS, 2020, 38, &#x27E8;10.1016/j.nmni.2020.100759&#x27E9;. &#x27E8;hal-03149261&#x27E9;",https://hal-amu.archives-ouvertes.fr/hal-03149261
80,3349858,"Jérôme Montnach, Isabelle Baró, Flavien Charpentier, Michel de Waard, Gildas Loussouarn. Modeling sudden cardiac death risks factors in COVID-19 patients -the hydroxychloroquine and azithromycin case. EP-Europace, Oxford University Press (OUP): Policy B, 2021, &#x27E8;10.1093/europace/euab043&#x27E9;. &#x27E8;hal-03349858&#x27E9;",http://hal.univ-nantes.fr/hal-03349858
81,3160847,"Jérôme Montnach, Isabelle Baró, Flavien Charpentier, Michel de Waard, Gildas Loussouarn. Modeling sudden cardiac death risks factors in COVID-19 patients -the hydroxychloroquine and azithromycin case. 2021. &#x27E8;hal-03160847&#x27E9;",http://hal.univ-nantes.fr/hal-03160847
82,1064913,"R. Khayat, A. Dupuy, I. Pansé, M. Bagot, F. Cordoliani. [Sclerodermatous changes in porphyria cutanea tarda: six cases]. Annales de Dermatologie et de Vénéréologie, Elsevier Masson, 2013, 140 (10), pp.589--597. &#x27E8;10.1016/j.annder.2013.04.092&#x27E9;. &#x27E8;hal-01064913&#x27E9;",https://hal.archives-ouvertes.fr/hal-01064913
83,1791229,"Nathalie Costedoat-Chalumeau, Jacques Pouchot, Gaëlle Guettrot-Imbert, Veronique Le Guern, Gaëlle Leroux, et al.. Adherence to treatment in systemic lupus erythematosus patients. Best Practice and Research: Clinical Rheumatology, Elsevier, 2013, 27 (3), pp.329 - 340. &#x27E8;10.1016/j.berh.2013.07.001&#x27E9;. &#x27E8;hal-01791229&#x27E9;",https://hal.univ-lorraine.fr/hal-01791229
84,1318201,"Loraine Gaüzère. Caractéristiques épidémiologiques, cliniques et biologiques du lupus érythémateux systémique au CHU de Saint-Denis : étude rétrospective de janvier 2004 à juillet 2015. Médecine humaine et pathologie. 2016. &#x27E8;dumas-01318201&#x27E9;",https://dumas.ccsd.cnrs.fr/dumas-01318201
85,1985089,Diane Riehl. Neuro-psychiatric manifestations in systemic lupus erythematosus: new concepts from a mono-center retrospective study. Human health and pathology. 2018. &#x27E8;dumas-01985089&#x27E9;,https://dumas.ccsd.cnrs.fr/dumas-01985089
86,3139171,"Coralie Di Scala, Jacques Fantini, Henri Chahinian, Nouara Yahi. Structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against SARS-CoV-2 infection. International Journal of Antimicrobial Agents, Elsevier, 2020, 55, pp.105960. &#x27E8;10.1016/j.ijantimicag.2020.105960&#x27E9;. &#x27E8;hal-03139171&#x27E9;",https://hal-amu.archives-ouvertes.fr/hal-03139171
87,3139164,"Jacques Fantini, Henri Chahinian, Nouara Yahi. Leveraging coronavirus binding to gangliosides for innovative vaccine and therapeutic strategies against COVID-19. Biochemical and Biophysical Research Communications, Elsevier, 2020, 538, pp.132-136. &#x27E8;10.1016/j.bbrc.2020.10.015&#x27E9;. &#x27E8;hal-03139164&#x27E9;",https://hal-amu.archives-ouvertes.fr/hal-03139164
88,2101028,Annabel Boyer. Néphropathie associée à une vascularite urticarienne hypocomplémentémique : présentation d'un cas clinique et revue de la littérature. Médecine humaine et pathologie. 2018. &#x27E8;dumas-02101028&#x27E9;,https://dumas.ccsd.cnrs.fr/dumas-02101028
89,3211436,"Matthieu Million, Herve Chaudet, Didier Raoult. Hydroxychloroquine Failure: The End Does Not Justify the Means. Clinical Infectious Diseases, Oxford University Press (OUP), 2020, &#x27E8;10.1093/cid/ciaa1117&#x27E9;. &#x27E8;hal-03211436&#x27E9;",https://hal-amu.archives-ouvertes.fr/hal-03211436
90,3149722,"Joana Vitte, Moise Michel, Soraya Mezouar, Aissatou Bailo Diallo, Asma Boumaza, et al.. Immune Modulation as a Therapeutic Option During the SARS-CoV-2 Outbreak: The Case for Antimalarial Aminoquinolines. Frontiers in Immunology, Frontiers, 2020, 11, &#x27E8;10.3389/fimmu.2020.02159&#x27E9;. &#x27E8;hal-03149722&#x27E9;",https://hal-amu.archives-ouvertes.fr/hal-03149722
91,3304670,"Philippe Gautret, van Thuan Hoang, Philippe Colson, Didier Raoult. Effect of hydroxychloroquine and azithromycin on the viral clearance of SARS-CoV-2: response to Hervé Seligmann. International Journal of Antimicrobial Agents, Elsevier, 2021, 57 (3), pp.106306. &#x27E8;10.1016/j.ijantimicag.2021.106306&#x27E9;. &#x27E8;hal-03304670&#x27E9;",https://hal-amu.archives-ouvertes.fr/hal-03304670
92,3216101,"Philippe Gautret, van Thuan Hoang, Jean-Christophe Lagier, Didier Raoult. Effect of hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial, an update with an intention-to-treat analysis and clinical outcomes. International Journal of Antimicrobial Agents, Elsevier, 2021, 57 (1), pp.106239. &#x27E8;10.1016/j.ijid.2020.10.005&#x27E9;. &#x27E8;hal-03216101&#x27E9;",https://hal-amu.archives-ouvertes.fr/hal-03216101
93,3215794,"Matthieu Million, Yanis Roussel, Philippe Gautret, Didier Raoult. Effect of hydroxychloroquine and azithromycin on SARS-CoV-2 clearance in COVID-19 patients, a meta-analysis.. International Journal of Antimicrobial Agents, Elsevier, 2021, 57 (1), pp.106240. &#x27E8;10.1016/j.ijantimicag.2020.106240&#x27E9;. &#x27E8;hal-03215794&#x27E9;",https://hal-amu.archives-ouvertes.fr/hal-03215794
94,3215745,"Philippe Gautret, van Thuan Hoang, Hervé Chaudet, Jean-Christophe Lagier, Didier Raoult. Response to uncertain effect of hydroxychloroquine and azithromycin on SARS-CoV-2 viral load.. International Journal of Antimicrobial Agents, Elsevier, 2021, 57 (1), pp.106244. &#x27E8;10.1016/j.ijantimicag.2020.106244&#x27E9;. &#x27E8;hal-03215745&#x27E9;",https://hal-amu.archives-ouvertes.fr/hal-03215745
95,3215708,"Philippe Gautret, van Thuan Hoang, Jean-Christophe Lagier, Didier Raoult. Response to effect estimation of hydroxychloroquine for COVID-19: a secondary analysis of an open label non-randomized clinical trial.. International Journal of Antimicrobial Agents, Elsevier, 2021, 57 (1), pp.106237. &#x27E8;10.1016/j.ijantimicag.2020.106237&#x27E9;. &#x27E8;hal-03215708&#x27E9;",https://hal-amu.archives-ouvertes.fr/hal-03215708
96,3304672,"Philippe Gautret, Tran Duc Anh Ly, Didier Raoult. Hydroxychloroquine + azithromycin treatment in elderly patients. International Journal of Antimicrobial Agents, Elsevier, 2021, 57 (4), pp.106313. &#x27E8;10.1016/j.ijantimicag.2021.106313&#x27E9;. &#x27E8;hal-03304672&#x27E9;",https://hal-amu.archives-ouvertes.fr/hal-03304672
97,3211439,"Matthieu Million, Audrey Giraud-Gatineau, Jean-Christophe Lagier, Philippe Parola, Philippe Gautret, et al.. Reply to Lebeaux D, Revest M. No evidence of clinical benefits of early treatment of COVID-19 patients with hydroxychloroquine and azithromycin. Travel Medicine and Infectious Disease, Elsevier, 2021, 39, pp.101954. &#x27E8;10.1016/j.tmaid.2020.101954&#x27E9;. &#x27E8;hal-03211439&#x27E9;",https://hal-amu.archives-ouvertes.fr/hal-03211439
98,2347272,"A Schmidt-Tanguy, J Voswinkel, D Henrion, Jf Subra, L. Loufrani, et al.. Anti-thrombotic effects of hydroxychloroquine in primary antiphospholipid syndrome patients. Journal of Thrombosis and Haemostasis, Wiley, 2013, pp.n/a-n/a. &#x27E8;10.1111/jth.12363&#x27E9;. &#x27E8;hal-02347272&#x27E9;",https://hal.archives-ouvertes.fr/hal-02347272
99,3154562,"Yudibeth Sixto-López, José Correa-Basurto, Martiniano Bello, Bruno Landeros-Rivera, Jose Garzón-Tiznado, et al.. Structural insights into SARS-CoV-2 spike protein and its natural mutants found in Mexican population. Scientific Reports, Nature Publishing Group, 2021, 11, pp.4659. &#x27E8;10.1038/s41598-021-84053-8&#x27E9;. &#x27E8;hal-03154562&#x27E9;",https://hal.sorbonne-universite.fr/hal-03154562
100,1150503,"Alain Saraux. The point on the ongoing B-cell depleting trials currently in progress over the world in primary Sjögren's syndrome.. Autoimmunity Reviews, Elsevier, 2010, 9 (9), pp.609-14. &#x27E8;hal-01150503&#x27E9;",https://hal.archives-ouvertes.fr/hal-01150503
101,3190750,"Clara Locher, David Moher, Ioana Alina Cristea, Florian Naudet. Publication by association: how the COVID-19 pandemic has shown relationships between authors and editorial board members in the field of infectious diseases. Bmj Evidence-Based Medicine, 2021, pp.bmjebm-2021-111670. &#x27E8;10.1136/bmjebm-2021-111670&#x27E9;. &#x27E8;hal-03190750&#x27E9;",https://hal.archives-ouvertes.fr/hal-03190750
102,3280784,"Stéphane Honoré, Philippe Gautret. Reply to Alizazgar J. Dangers of the use of hydroxychloroquine and azithromycin combination in COVID-19 patients. Travel Medicine and Infectious Disease, Elsevier, 2021, 40, pp.101984. &#x27E8;10.1016/j.tmaid.2021.101984&#x27E9;. &#x27E8;hal-03280784&#x27E9;",https://hal-amu.archives-ouvertes.fr/hal-03280784
103,2444342,"E. Pasquier, L. de Saint Martin, C. Chauleur, C. Bohec, F. Bretelle, et al.. P004: Hydroxychloroquine for prevention of recurrent miscarriage: study protocol of an ongoing French multicenter randomized placebo-controlled trial. Thrombosis Research, Elsevier, 2019, 175, pp.S7-S8. &#x27E8;10.1016/S0049-3848(19)30099-4&#x27E9;. &#x27E8;hal-02444342&#x27E9;",https://hal-amu.archives-ouvertes.fr/hal-02444342
104,3203545,"Alexandre Hocquet. Open Science in Times of Coronavirus: Introducing the Concept of Real-Time Publication. SubStance, University of Wisconsin Press, 2020, 4 (1). &#x27E8;hal-03203545&#x27E9;",https://hal.archives-ouvertes.fr/hal-03203545
105,1879626,"Loukman Omarjee, Vincent Jaquinandi, Audrey Camarzana, Frederic Rouleau, Tin-Hinan Mezdad, et al.. Improvement of Libman-Sacks Endocarditis With Combined Hydroxychloroquine-Vitamin K Antagonist Therapy in a Primary Antiphospholipid Syndrome Patient. Circulation Journal, Japanese Circulation Society, 2018, 82 (9), pp.2380-2382. &#x27E8;10.1253/circj.CJ-17-1131&#x27E9;. &#x27E8;hal-01879626&#x27E9;",https://hal-univ-rennes1.archives-ouvertes.fr/hal-01879626
106,3339017,"Alexandre Thibault Jacques Maria, Isabelle Diaz-Cau, Jean-Marc Benejean, Anaïs Nutz, Aurélie Schiffmann, et al.. Flare of Antiphospholipid Syndrome in the Course of COVID-19. TH Open : Companion Journal To Thrombosis and Haemostasis, Thieme, 2020, 04 (03), pp.e207-e210. &#x27E8;10.1055/s-0040-1716735&#x27E9;. &#x27E8;hal-03339015&#x27E9;",https://hal.umontpellier.fr/hal-03339015
107,1006522,"A. Bouaziz, J. Le Scanff, C. Chapelon-Abric, L. Varron, S. Khenifer, et al.. Oral involvement in sarcoidosis: report of 12 cases.. QJM: An International Journal of Medicine, Oxford University Press (OUP), 2012, 105 (8), pp.755-67. &#x27E8;10.1093/qjmed/hcs042&#x27E9;. &#x27E8;hal-01006522&#x27E9;",https://hal.archives-ouvertes.fr/hal-01006522
108,3367653,"Yamina Hamel, François-Xavier Mauvais, Marine Madrange, Perrine Renard, Corinne Lebreton, et al.. Compromised mitochondrial quality control triggers lipin1-related rhabdomyolysis. Cell Reports Medicine, Cell Press, 2021, 2 (8), pp.100370. &#x27E8;10.1016/j.xcrm.2021.100370&#x27E9;. &#x27E8;hal-03367653&#x27E9;",https://hal.archives-ouvertes.fr/hal-03367653
109,2404931,"Elisabeth Pasquier, Luc de Saint-Martin, Gisèle Marhic, Céline Chauleur, Caroline Bohec, et al.. Hydroxychloroquine for prevention of recurrent miscarriage: study protocol for a multicentre randomised placebo-controlled trial BBQ study. BMJ Open, BMJ Publishing Group, 2019, 9 (3), pp.e025649. &#x27E8;10.1136/bmjopen-2018-025649&#x27E9;. &#x27E8;hal-02082511&#x27E9;",https://hal.univ-brest.fr/hal-02082511
110,3208384,"Guillaume Lano, Antoine Braconnier, Stanislas Bataille, Guilhem Cavaille, Julie Moussi-Frances, et al.. Risk factors for severity of COVID-19 in chronic dialysis patients from a multicentre French cohort. Clinical Kidney Journal, Oxford University Press, 2020, 13 (5), pp.878-888. &#x27E8;10.1093/ckj/sfaa199&#x27E9;. &#x27E8;hal-03208384&#x27E9;",https://hal-amu.archives-ouvertes.fr/hal-03208384
111,3278006,"F. Lamazou, P. Oger, R. Dieli-Crimi, A. Guerin, V. Letouzey, et al.. COVID-19 infection in first trimester of pregnancy marked by a liver cytolysis in a woman previously treated by hydroxychloroquine for repeated implantation failure: a case report. BMC Infectious Diseases, BioMed Central, 2020, 20, pp.845. &#x27E8;10.1186/s12879-020-05551-0&#x27E9;. &#x27E8;hal-03278006&#x27E9;",https://hal.umontpellier.fr/hal-03278006
112,3240528,"Perrine Janiaud, Cathrine Axfors, Janneke Van’t Hooft, Ramon Saccilotto, Arnav Agarwal, et al.. The worldwide clinical trial research response to the COVID-19 pandemic - the first 100 days.. F1000Research, Faculty of 1000, 2020, 9, pp.1193. &#x27E8;10.12688/f1000research.26707.2&#x27E9;. &#x27E8;hal-03000824&#x27E9;",https://hal.archives-ouvertes.fr/hal-03000824
113,3099397,"Carlotta Cacciatore, Pierre Belnou, Sara Thietart, Carole Desthieux, Mathilde Versini, et al.. Acute and Chronic Sarcoid Arthropathies: Characteristics and Treatments From a Retrospective Nationwide French Study. Frontiers in Medicine, Frontiers media, 2020, 7, &#x27E8;10.3389/fmed.2020.565420&#x27E9;. &#x27E8;hal-03099397&#x27E9;",https://hal.sorbonne-universite.fr/hal-03099397
114,2938930,"Tamim Alsuliman, Lugien Alasadi, Banan Alkharat, Micha Srour, Ali Alrstom. A review of potential treatments to date in COVID-19 patients according to the stage of the disease. Current Research in Translational Medicine, Elsevier-Masson SAS, 2020, 68 (3), pp.93-104. &#x27E8;10.1016/j.retram.2020.05.004&#x27E9;. &#x27E8;hal-02938930&#x27E9;",https://hal.sorbonne-universite.fr/hal-02938930
115,99876,"Christophe Biot, Wassim Daher, Natascha Chavain, Thierry Fandeur, Jamal Khalife, et al.. Design and Synthesis of Hydroxyferroquine Derivatives with Antimalarial and Antiviral Activities. Journal of Medicinal Chemistry, American Chemical Society, 2006, 49, pp.2845. &#x27E8;10.1021/jm0601856&#x27E9;. &#x27E8;hal-00099876&#x27E9;",https://hal.archives-ouvertes.fr/hal-00099876
116,2552186,"Alfred Kim, Jeffrey Sparks, Jean Liew, Michael Putman, Francis Berenbaum, et al.. A Rush to Judgment? Rapid Reporting and Dissemination of Results and Its Consequences Regarding the Use of Hydroxychloroquine for COVID-19. Annals of Internal Medicine, American College of Physicians, 2020, &#x27E8;10.7326/M20-1223&#x27E9;. &#x27E8;inserm-02552186&#x27E9;",https://www.hal.inserm.fr/inserm-02552186
117,3127829,"L. Larrouquere, M. Gabin, E. Poingt, A. Mouffak, A. Hlavaty, et al.. Genesis of an emergency public drug information website by the French Society of Pharmacology and Therapeutics during the COVID-19 pandemic. Fundamental and Clinical Pharmacology, Wiley, In press, 34 (3), pp.389-396. &#x27E8;10.1111/fcp.12564&#x27E9;. &#x27E8;hal-03127829&#x27E9;",https://hal.archives-ouvertes.fr/hal-03127829
118,3226395,"M. Jacquet-Lagrèze, Z. Riad, E. Hugon-Vallet, A. Ferraris, J. L. Fellahi. Left ventricular dysfunction in COVID-19: A diagnostic issue. Anaesthesia, Critical Care & Pain Medicine, 2020, 39 (3), pp.393-394. &#x27E8;10.1016/j.accpm.2020.05.015&#x27E9;. &#x27E8;inserm-03226395&#x27E9;",https://www.hal.inserm.fr/inserm-03226395
119,2985810,"Romy Sauvayre. Retour sur le débat médiatique et éthique concernant le traitement contre la Covid-19 à base de chloroquine. Les Cahiers de l'Espace Ethique, 2020, Hors-série, pp.91-92. &#x27E8;hal-02965645&#x27E9;",https://hal.archives-ouvertes.fr/hal-02965645
120,2525126,"Philippe Gautret, Jean-Christophe Lagier, Philippe Parola, van Thuan Hoang, Line Meddeb, et al.. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. International Journal of Antimicrobial Agents, Elsevier, 2020, pp.105949. &#x27E8;10.1016/j.ijantimicag.2020.105949&#x27E9;. &#x27E8;hal-02525126&#x27E9;",https://hal-amu.archives-ouvertes.fr/hal-02525126
121,2564271,"Bernard La Scola, Marion Le Bideau, Julien Andreani, van Thuan Hoang, Clio Grimaldier, et al.. Viral RNA load as determined by cell culture as a management tool for discharge of SARS-CoV-2 patients from infectious disease wards.. European Journal of Clinical Microbiology and Infectious Diseases, Springer Verlag, 2020, &#x27E8;10.1007/s10096-020-03913-9&#x27E9;. &#x27E8;hal-02564271&#x27E9;",https://hal-amu.archives-ouvertes.fr/hal-02564271
122,1859711,"S. Worm, J. B. Giot, C. Courtoy, E. Gillet, Sophie Amrane, et al.. A case of giant cell arteritis associated with culture-proven Coxiella burnetii aortitis. International Journal of Infectious Diseases, Elsevier, 2018, 69, pp.50-54. &#x27E8;10.1016/j.ijid.2018.01.028&#x27E9;. &#x27E8;hal-01791589&#x27E9;",https://hal.archives-ouvertes.fr/hal-01791589
123,3357937,"Esmaeil Mehraeen, Zeinab Najafi, Bagher Hayati, Mohammad Javaherian, Sajad Rahimi, et al.. Current Treatments and Therapeutic Options for COVID-19 Patients: A Systematic Review. Infectious Disorders - Drug Targets, Bentham Science Publishers, 2021, 21, &#x27E8;10.2174/1871526521666210726150435&#x27E9;. &#x27E8;hal-03357937&#x27E9;",https://hal-amu.archives-ouvertes.fr/hal-03357937
124,2948384,"Lee Nguyen, Charles Dolladille, Milou-Daniel Drici, Charlotte Fenioux, Joachim Alexandre, et al.. Cardiovascular Toxicities Associated With Hydroxychloroquine and Azithromycin. Circulation, American Heart Association, 2020, 142 (3), pp.303-305. &#x27E8;10.1161/CIRCULATIONAHA.120.048238&#x27E9;. &#x27E8;hal-02948384&#x27E9;",https://hal.sorbonne-universite.fr/hal-02948384
125,2964247,"Simon Funnell, William Dowling, César Muñoz-Fontela, Pierre-Stéphane Gsell, Donald Ingber, et al.. Emerging preclinical evidence does not support broad use of hydroxychloroquine in COVID-19 patients. Nature Communications, Nature Publishing Group, 2020, 11 (1), pp.4253. &#x27E8;10.1038/s41467-020-17907-w&#x27E9;. &#x27E8;inserm-02964247&#x27E9;",https://www.hal.inserm.fr/inserm-02964247
126,2883439,"Jean-Jacques Dubost, Marion Couderc, Sylvain Mathieu, Anne Tournadre, Martin Soubrier. Chronic bursitis and tenosynovitis revealing Whipple's disease. Joint Bone Spine, Elsevier Masson, 2020, 87 (5), pp.481-482. &#x27E8;10.1016/j.jbspin.2020.01.010&#x27E9;. &#x27E8;hal-02883439&#x27E9;",https://hal.archives-ouvertes.fr/hal-02883439
127,1764034,"Guillaume Taieb, Thibaut Allou, Pierre Labauge. Therapeutic Approaches in CLIPPERS. Current Treatment Options in Neurology, Current Medicine Group, 2017, 19 (5), pp.17. &#x27E8;10.1007/s11940-017-0455-4&#x27E9;. &#x27E8;hal-01764034&#x27E9;",https://hal.archives-ouvertes.fr/hal-01764034
128,3215698,"Philippe Gautret, Jean-Christophe Lagier, Stéphane Honoré, van Thuan Hoang, Philippe Colson, et al.. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial revisited. International Journal of Antimicrobial Agents, Elsevier, 2021, 57 (1), pp.106243. &#x27E8;10.1016/j.ijantimicag.2020.106243&#x27E9;. &#x27E8;hal-03215698&#x27E9;",https://hal-amu.archives-ouvertes.fr/hal-03215698
129,3215689,"Philippe Gautret, Jean-Christophe Lagier, Stéphane Honoré, van Thuan Hoang, Didier Raoult. Clinical efficacy and safety profile of hydroxychloroquine and azithromycin against COVID-19. International Journal of Antimicrobial Agents, Elsevier, 2021, 57 (1), pp.106242. &#x27E8;10.1016/j.ijantimicag.2020.106242&#x27E9;. &#x27E8;hal-03215689&#x27E9;",https://hal-amu.archives-ouvertes.fr/hal-03215689
130,3215703,"Philippe Gautret, Stéphane Honoré, Jean-Christophe Lagier, Didier Raoult. Safety profile of hydroxychloroquine and azithromycin combined treatment in COVID-19 patients. International Journal of Antimicrobial Agents, Elsevier, 2021, 57 (1), pp.106236. &#x27E8;10.1016/j.ijantimicag.2020.106236&#x27E9;. &#x27E8;hal-03215703&#x27E9;",https://hal-amu.archives-ouvertes.fr/hal-03215703
131,3215722,"Philippe Gautret, van Thuan Hoang, Stéphane Honoré, Yanis Roussel, Matthieu Million, et al.. Response to the use of hydroxychloroquine in combination with azithromycin for patients with COVID-19 is not supported by recent literature.. International Journal of Antimicrobial Agents, Elsevier, 2021, 57 (1), pp.106241. &#x27E8;10.1016/j.ijantimicag.2020.106241&#x27E9;. &#x27E8;hal-03215722&#x27E9;",https://hal-amu.archives-ouvertes.fr/hal-03215722
132,1775495,"Abinash Virk, Maryam Mahmood, Manju Kalra, Thomas C. Bower, Douglas R. Osmon, et al.. Coxiella burnetii Multilevel Disk Space Infection, Epidural Abscess, and Vertebral Osteomyelitis Secondary to Contiguous Spread From Infected Abdominal Aortic Aneurysm or Graft: Report of 4 Cases Acquired in the US and Review of the Literature. Open Forum Infectious Diseases, Oxford University Press, 2017, 4 (4), &#x27E8;10.1093/ofid/ofx192&#x27E9;. &#x27E8;hal-01730983&#x27E9;",https://hal.archives-ouvertes.fr/hal-01730983
133,2569423,"Christian Devaux, Jean-Marc Rolain, Philippe Colson, Didier Raoult. New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?. International Journal of Antimicrobial Agents, Elsevier, 2020, pp.105938. &#x27E8;10.1016/j.ijantimicag.2020.105938&#x27E9;. &#x27E8;hal-02517890&#x27E9;",https://hal-amu.archives-ouvertes.fr/hal-02517890
134,3077840,Karen Minary. Devenir à l’âge adulte des patients atteints de lupus érythémateux disséminé de révélation pédiatrique au CHU de Montpellier. Médecine humaine et pathologie. 2020. &#x27E8;dumas-03077840&#x27E9;,https://dumas.ccsd.cnrs.fr/dumas-03077840
135,2508327,"Clotilde Chatre, Nathalie Filippi, François Roubille, Yves-Marie Pers. Heart Involvement in a Woman Treated with Hydroxychloroquine for Systemic Lupus Erythematosus Revealing Fabry Disease. Journal of Rheumatology, Journal of Rheumatology Publishing Company Limited, 2016, 43 (5), pp.997 - 998. &#x27E8;10.3899/jrheum.151357&#x27E9;. &#x27E8;hal-01793104&#x27E9;",https://hal.umontpellier.fr/hal-01793104
136,3364426,"Florence Ader, Nathan Peiffer-Smadja, Julien Poissy, Maude Bouscambert-Duchamp, Drifa Belhadi, et al.. An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19. Clinical Microbiology and Infection, Elsevier for the European Society of Clinical Microbiology and Infectious Diseases, 2021, S1198-743X (21), pp.00259-7. &#x27E8;10.1016/j.cmi.2021.05.020&#x27E9;. &#x27E8;hal-03364426&#x27E9;",https://hal.archives-ouvertes.fr/hal-03364426
137,1936357,"Cristina Belizna, Francesca Pregnolato, Sébastien Abad, Jaume Alijotas-Reig, Howard Amital, et al.. HIBISCUS: Hydroxychloroquine for the secondary prevention of thrombotic and obstetrical events in primary antiphospholipid syndrome. Autoimmunity Reviews, Elsevier, 2018, 17 (12), pp.1153 - 1168. &#x27E8;10.1016/j.autrev.2018.05.012&#x27E9;. &#x27E8;hal-01936357&#x27E9;",https://hal-univ-rennes1.archives-ouvertes.fr/hal-01936357
138,1086394,"Muhammad Zaeem Noman. Influence of hypoxia on tumour cell susceptibility to cytotoxic T lymphocyte mediated lysis. Cancer. Université Paris Sud - Paris XI, 2012. English. &#x27E8;NNT : 2012PA11T051&#x27E9;. &#x27E8;tel-01024170&#x27E9;",https://tel.archives-ouvertes.fr/tel-01024170
139,1290818,"Marie-Blandine Gottis. Épidémiologie des infections chroniques à Coxiella Burnetii sur l’île de la Réunion, une étude rétrospective de 2007 à 2015. Médecine humaine et pathologie. 2016. &#x27E8;dumas-01290818&#x27E9;",https://dumas.ccsd.cnrs.fr/dumas-01290818
140,2291291,"Imen Ben Hassine, Christopher Rein, Cloé Comarmond, Camille Glanowski, Nathalie Saidenberg-Kermanac’h, et al.. Osseous sarcoidosis: a multicenter case-control study. Joint Bone Spine, Elsevier Masson, In press, &#x27E8;10.1016/j.jbspin.2019.07.009&#x27E9;. &#x27E8;hal-02291291&#x27E9;",https://hal.sorbonne-universite.fr/hal-02291291
141,2991815,"Alexis Mathian, Matthieu Mahevas, Julien Rohmer, Mathilde Roumier, Fleur Cohen-Aubart, et al.. Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine.. Annals of the Rheumatic Diseases, BMJ Publishing Group, 1970, 79 (6), pp.837-839. &#x27E8;10.1136/annrheumdis-2020-217566&#x27E9;. &#x27E8;hal-02626065&#x27E9;",https://hal.sorbonne-universite.fr/hal-02626065
142,3138793,"Jean-Christophe Lagier, Matthieu Million, Philippe Gautret, Philippe Colson, Sébastien Cortaredona, et al.. Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis. Travel Medicine and Infectious Disease, Elsevier, 2020, 36, pp.101791. &#x27E8;10.1016/j.tmaid.2020.101791&#x27E9;. &#x27E8;hal-03138793&#x27E9;",https://hal-amu.archives-ouvertes.fr/hal-03138793
143,2262294,"Sébastien Miranda, Paul Billoir, Louise Damian, Pierre Thiebaut, Damien Schapman, et al.. Hydroxychloroquine reverses the prothrombotic state in a mouse model of antiphospholipid syndrome: Role of reduced inflammation and endothelial dysfunction. PLoS ONE, Public Library of Science, 2019, 14 (3), pp.e0212614. &#x27E8;10.1371/journal.pone.0212614&#x27E9;. &#x27E8;inserm-02262294&#x27E9;",https://www.hal.inserm.fr/inserm-02262294
144,2296602,"Sébastien Miranda, Paul Billoir, Louise Damian, Pierre Alain Thiebaut, Damien Schapman, et al.. Hydroxychloroquine reverses the prothrombotic state in a mouse model of antiphospholipid syndrome: Role of reduced inflammation and endothelial dysfunction. PLoS ONE, Public Library of Science, 2019, 14 (3), pp.e0212614. &#x27E8;10.1371/journal.pone.0212614&#x27E9;. &#x27E8;inserm-02296602&#x27E9;",https://www.hal.inserm.fr/inserm-02296602
145,2988307,"Antonio Gonçalves, Julie Bertrand, Ruian Ke, Emmanuelle Comets, Xavier De Lamballerie, et al.. Timing of Antiviral Treatment Initiation is Critical to Reduce SARS‐CoV‐2 Viral Load. CPT: Pharmacometrics and Systems Pharmacology, American Society for Clinical Pharmacology and Therapeutics ; International Society of Pharmacometrics, 2020, 9 (9), pp.509-514. &#x27E8;10.1002/psp4.12543&#x27E9;. &#x27E8;hal-02972962&#x27E9;",https://hal.archives-ouvertes.fr/hal-02972962
146,3218291,"Arnold Sadio, Fifonsi Gbeasor-Komlanvi, Rodion Konu, Akila Bakoubayi, Martin Tchankoni, et al.. Assessment of self-medication practices in the context of the COVID-19 outbreak in Togo. BMC Public Health, BioMed Central, 2021, 21 (1), pp.58. &#x27E8;10.1186/s12889-020-10145-1&#x27E9;. &#x27E8;inserm-03218291&#x27E9;",https://www.hal.inserm.fr/inserm-03218291
147,759192,"Sophie Besnard, Anne Cady, Erwan Flecher, Fabien Fily, Matthieu Revest, et al.. Should we systematically perform central nervous system imaging in patients with Whipple's endocarditis?. The american journal of medicine, 2010, 123 (10), pp.962.e1-4. &#x27E8;10.1016/j.amjmed.2010.04.030&#x27E9;. &#x27E8;hal-00759192&#x27E9;",https://hal.archives-ouvertes.fr/hal-00759192
148,1910336,"Lucie Wartique, Jean-Christophe Lagier, Didier Raoult, Yvan Jamilloux, Pascal Seve. Mesenteric lymphadenitis as a presenting feature of Whipple's disease: Value of PCR analysis. International Journal of Infectious Diseases, Elsevier, 2018, 75, pp.15-17. &#x27E8;10.1016/j.ijid.2018.08.003&#x27E9;. &#x27E8;hal-01910336&#x27E9;",https://hal.archives-ouvertes.fr/hal-01910336
149,3170721,"Cédric Annweiler, Bérangère Hanotte, Claire Grandin de l'Eprevier, Jean-Marc Sabatier, Ludovic Lafaie, et al.. Vitamin D and survival in COVID-19 patients: A quasi-experimental study. The Journal of Steroid Biochemistry and Molecular Biology, 2020, 204, pp.105771. &#x27E8;10.1016/j.jsbmb.2020.105771&#x27E9;. &#x27E8;hal-03170721&#x27E9;",https://hal-amu.archives-ouvertes.fr/hal-03170721
150,1791673,"Zakaria Jalal, Marie Duperril, Pierre-Emmanuel Seguela, Clea Melenotte, Julie Chabaneix, et al.. First Case of Q Fever Endocarditis Involving the Melody(A (R)) Transcatheter Pulmonary Valve in an Afebrile Child. Pediatric Cardiology, Springer Verlag, 2018, 39 (1), pp.195-197. &#x27E8;10.1007/s00246-017-1723-5&#x27E9;. &#x27E8;hal-01791673&#x27E9;",https://hal.archives-ouvertes.fr/hal-01791673
151,3231950,"Christian Dejaco, Alessia Alunno, Johannes Wj Bijlsma, Annelies Boonen, Bernard Combe, et al.. Influence of COVID-19 pandemic on decisions for the management of people with inflammatory rheumatic and musculoskeletal diseases: a survey among EULAR countries. Annals of the Rheumatic Diseases, BMJ Publishing Group, 2021, 80 (4), pp.518-526. &#x27E8;10.1136/annrheumdis-2020-218697&#x27E9;. &#x27E8;hal-03231950&#x27E9;",https://hal.umontpellier.fr/hal-03231950
152,2938916,"Elise Roumeau. ""Essais cliniques en situation de pandémie : quelles sont les règles ?"". The Conversation, The Conversation France, 2020. &#x27E8;hal-02557336&#x27E9;",https://hal.uca.fr/hal-02557336
153,2976748,"Benjamin Davido, Ghilas Boussaid, Isabelle Vaugier, Thibaud Lansaman, Frédérique Bouchand, et al.. Impact of medical care, including use of anti-infective agents, on prognosis of COVID-19 hospitalized patients over time. International Journal of Antimicrobial Agents, Elsevier, 2020, 56 (4), pp.106129. &#x27E8;10.1016/j.ijantimicag.2020.106129&#x27E9;. &#x27E8;hal-02976748&#x27E9;",https://hal.uvsq.fr/hal-02976748
154,945425,"Jean-Nicolas Boursiquot, Laurence Gérard, Marion Malphettes, Claire Fieschi, Lionel Galicier, et al.. Granulomatous disease in CVID: retrospective analysis of clinical characteristics and treatment efficacy in a cohort of 59 patients.. Journal of Clinical Immunology, Springer Verlag, 2013, 33 (1), pp.84-95. &#x27E8;10.1007/s10875-012-9778-9&#x27E9;. &#x27E8;hal-00945425&#x27E9;",https://hal.archives-ouvertes.fr/hal-00945425
155,1859856,"Patricia El Boustany, Ralph Epaud, Camille Grosse, Francois Barriere, Élisabeth Grimont-Rolland, et al.. Unusual long survival despite severe lung disease of a child with biallelic loss of function mutations in ABCA-3. Respiratory Medicine Case Reports, 2018, 23, pp.173-175. &#x27E8;10.1016/j.rmcr.2018.03.004&#x27E9;. &#x27E8;hal-01858937&#x27E9;",https://hal.archives-ouvertes.fr/hal-01858937
156,3132556,"J-S Allain, E Paven, B Henriot, N Belhomme, A Le Bot, et al.. Une endocardite de Libman-Sacks survenant sous apixaban chez une patiente atteinte de SAPL veineux de profil à haut risque. La Revue De Médecine Interne, Elsevier, 2021, 42 (3), pp.218-222. &#x27E8;10.1016/j.revmed.2020.08.009&#x27E9;. &#x27E8;hal-03000956&#x27E9;",https://hal.archives-ouvertes.fr/hal-03000956
157,3135953,"Paul Bertin, Kenzo Nera, Sylvain Delouvée. Conspiracy Beliefs, Rejection of Vaccination, and Support for hydroxychloroquine: A Conceptual Replication-Extension in the COVID-19 Pandemic Context. Frontiers in Psychology, Frontiers, 2020, 11, &#x27E8;10.3389/fpsyg.2020.565128&#x27E9;. &#x27E8;hal-03135953&#x27E9;",https://hal.archives-ouvertes.fr/hal-03135953
158,3414531,"Vincent Gies, Nassima Bekaddour, Yannick Dieudonné, Aurélien Guffroy, Quentin Frenger, et al.. Beyond Anti-viral Effects of Chloroquine/Hydroxychloroquine. Frontiers in Immunology, Frontiers, 2020, 11, &#x27E8;10.3389/FIMMU.2020.01409&#x27E9;. &#x27E8;hal-02996379&#x27E9;",https://hal.archives-ouvertes.fr/hal-02996379
159,2978643,"Benoit Blanchet, Moez Jallouli, Marie Allard, Pascale Ghillani-Dalbin, Lionel Galicier, et al.. Hydroxychloroquine levels in patients with systemic lupus erythematosus: whole blood is preferable but serum levels also detect non-adherence. Arthritis Research and Therapy, BioMed Central, 2020, 22 (1), pp.223. &#x27E8;10.1186/s13075-020-02291-z&#x27E9;. &#x27E8;hal-02978643&#x27E9;",https://hal.sorbonne-universite.fr/hal-02978643
160,2988306,"Pauline Maisonnasse, Jérémie Guedj, Vanessa Contreras, Sylvie Behillil, Caroline Solas, et al.. Hydroxychloroquine use against SARS-CoV-2 infection in non-human primates. Nature, Nature Publishing Group, 2020, 585 (7826), pp.584-587. &#x27E8;10.1038/s41586-020-2558-4&#x27E9;. &#x27E8;hal-02907032&#x27E9;",https://hal.archives-ouvertes.fr/hal-02907032
161,933279,"Nathalie Costedoat-Chalumeau, Lionel Galicier, Olivier Aumaître, Camille Francès, Véronique Le Guern, et al.. Hydroxychloroquine in systemic lupus erythematosus: results of a French multicentre controlled trial (PLUS Study).. Annals of the Rheumatic Diseases, BMJ Publishing Group, 2013, 72 (11), pp.1786-92. &#x27E8;10.1136/annrheumdis-2012-202322&#x27E9;. &#x27E8;hal-00933279&#x27E9;",https://hal.univ-brest.fr/hal-00933279
162,1272718,"M Jallouli, L Galicier, N Zahr, O Aumaître, C Francès, et al.. Determinants of hydroxychloroquine blood concentration variations in systemic lupus erythematosus.. Arthritis & rheumatology, Wiley, 2015, 67 (8), pp.2176-84. &#x27E8;10.1002/art.39194&#x27E9;. &#x27E8;hal-01272718&#x27E9;",https://hal.univ-brest.fr/hal-01272718
163,3207911,"Anne-Laure Gérard, Noémie Simon-Tillaux, Youri Yordanov, Patrice Cacoub, Florence Tubach, et al.. Efficacy and safety of steroid-sparing treatments in giant cell arteritis according to the glucocorticoids tapering regimen: A systematic review and meta-analysis. European Journal of Internal Medicine, Elsevier, 2021, &#x27E8;10.1016/j.ejim.2021.03.040&#x27E9;. &#x27E8;hal-03207911&#x27E9;",https://hal.sorbonne-universite.fr/hal-03207911
164,3356840,"Laure Kamus, Bénédicte Roquebert, Jérôme Allyn, Nicolas Allou, Dorothée Valance, et al.. Severe bilateral pleuropneumonia caused by Legionella sainthelensi: a case report. BMC Infectious Diseases, BioMed Central, 2021, 21 (1), pp.966. &#x27E8;10.1186/s12879-021-06651-1&#x27E9;. &#x27E8;inserm-03356840&#x27E9;",https://www.hal.inserm.fr/inserm-03356840
165,1064616,"Arsène Mekinian, Thorsten Braun, Olivier Decaux, Géraldine Falgarone, Eric Toussirot, et al.. Inflammatory arthritis in patients with myelodysplastic syndromes: a multicenter retrospective study and literature review of 68 cases. Medicine, Lippincott, Williams & Wilkins, 2014, 93 (1), pp.1--10. &#x27E8;10.1097/MD.0000000000000011&#x27E9;. &#x27E8;hal-01064616&#x27E9;",https://hal.archives-ouvertes.fr/hal-01064616
166,3149233,"Tran Duc Anh Ly, Didier Zanini, Vincent Laforge, Sylvie Arlotto, Stephanie Gentile, et al.. Pattern of SARS-CoV-2 infection among dependant elderly residents living in long-term care facilities in Marseille, France, March-June 2020. International Journal of Antimicrobial Agents, 2020, 56 (6), &#x27E8;10.1016/j.ijantimicag.2020.106219&#x27E9;. &#x27E8;hal-03149233&#x27E9;",https://hal-amu.archives-ouvertes.fr/hal-03149233
167,2693984,"Frédéric Carrière, Sonia Longhi, Michel Record. The endosomal lipid bis(monoacylglycero) phosphate as a potential key player in the mechanism of action of chloroquine against SARS-COV-2 and other enveloped viruses hijacking the endocytic pathway. Biochimie, Elsevier, 2020, 179, pp.237-246. &#x27E8;10.1016/j.biochi.2020.05.013&#x27E9;. &#x27E8;hal-02693984&#x27E9;",https://hal.archives-ouvertes.fr/hal-02693984
168,3150054,"Elodie Riviere, Juliette Pascaud, Nicolas Tchitchek, Saida Boudaoud, Audrey Paoletti, et al.. Salivary gland epithelial cells from patients with Sjögren's syndrome induce B-lymphocyte survival and activation. Annals of the Rheumatic Diseases, BMJ Publishing Group, 2020, 79 (11), pp.1468-1477. &#x27E8;10.1136/annrheumdis-2019-216588&#x27E9;. &#x27E8;inserm-03150054&#x27E9;",https://www.hal.inserm.fr/inserm-03150054
169,2912487,"Sok‐sithikun Bun, Philippe Taghji, Johan Courjon, Fabien Squara, Didier Scarlatti, et al.. QT Interval Prolongation Under Hydroxychloroquine/Azithromycin Association for Inpatients With SARS‐CoV‐2 Lower Respiratory Tract Infection. Clinical Pharmacology and Therapeutics, American Society for Clinical Pharmacology and Therapeutics, 2020, 108 (5), pp.1090-1097. &#x27E8;10.1002/cpt.1968&#x27E9;. &#x27E8;hal-02912487&#x27E9;",https://hal-amu.archives-ouvertes.fr/hal-02912487
170,3343259,"Guilhem Bousquet, Géraldine Falgarone, David Deutsch, Sophie Derolez, Marilucy Lopez-Sublet, et al.. ADL-dependency, D-Dimers, LDH and absence of anticoagulation are independently associated with one-month mortality in older inpatients with Covid-19. Aging, Impact Journals, 2020, 12 (12), pp.11306-11313. &#x27E8;10.18632/aging.103583&#x27E9;. &#x27E8;inserm-03343259&#x27E9;",https://www.hal.inserm.fr/inserm-03343259
171,1611806,Cécile Saint-Pastou Terrier.  Évaluer la dose optimale de glucocorticoïdes pour traiter la néphrite lupique : une collaboration entre Bordeaux et Bilbao. Médecine humaine et pathologie. 2017. &#x27E8;dumas-01611806&#x27E9;,https://dumas.ccsd.cnrs.fr/dumas-01611806
172,2898074,"Md. Tanvir Kabir, Md. Sahab Uddin, Md. Farhad Hossain, Jawaher A. Abdulhakim, Md. Asraful Alam, et al.. nCOVID-19 Pandemic: From Molecular Pathogenesis to Potential Investigational Therapeutics. Frontiers in Cell and Developmental Biology, Frontiers media, 2020, 8, &#x27E8;10.3389/fcell.2020.00616&#x27E9;. &#x27E8;hal-02898074&#x27E9;",https://hal.archives-ouvertes.fr/hal-02898074
173,2995319,"Emilie Sbidian, Julie Josse, Guillaume Lemaître, Imke Mayer, Melodie Bernaux, et al.. Hydroxychloroquine with or without azithromycin and in-hospital mortality or discharge in patients hospitalized for COVID-19 infection: a cohort study of 4,642 in-patients in France. 2020. &#x27E8;hal-02995319&#x27E9;",https://hal.archives-ouvertes.fr/hal-02995319
174,2466239,"L. Olivier-Gougenheim, C. Freychet, S. Collardeau-Frachon, C. Roure-Sobas, S. Di Filippo, et al.. A quest for Q fever. LANCET, 2019, 394 (10196), pp.419. &#x27E8;10.1016/s0140-6736(19)31675-7&#x27E9;. &#x27E8;hal-02466239&#x27E9;",https://hal.archives-ouvertes.fr/hal-02466239
175,2178935,"Laure Ricard, Vincent Jachiet, Florent Malard, Yishan Ye, Nicolas Stocker, et al.. Circulating follicular helper T cells are increased in systemic sclerosis and promote plasmablast differentiation through the IL-21 pathway which can be inhibited by ruxolitinib. Annals of the Rheumatic Diseases, BMJ Publishing Group, 2019, 78 (4), pp.539-550. &#x27E8;10.1136/annrheumdis-2018-214382&#x27E9;. &#x27E8;hal-02178935&#x27E9;",https://hal.sorbonne-universite.fr/hal-02178935
176,3141170,"G Solé, E Salort-Campana, Y Pereon, T Stojkovic, K Wahbi, et al.. Guidance for the care of neuromuscular patients during the COVID-19 pandemic outbreak from the French Rare Health Care for Neuromuscular Diseases Network.. Revue Neurologique, Elsevier Masson, 2020, Revue Neurologique, 176 (6), pp.507-515. &#x27E8;10.1016/j.neurol.2020.04.004&#x27E9;. &#x27E8;hal-03141170&#x27E9;",https://hal.univ-lille.fr/hal-03141170
177,2924300,"Margaux Louchet, Jeanne Sibiude, Gilles Peytavin, Olivier Picone, Jean-Marc Tréluyer, et al.. Placental transfer and safety in pregnancy of medications under investigation to treat coronavirus disease 2019. American Journal of Obstetrics & Gynecology MFM, 2020, 2 (3), pp.100159. &#x27E8;10.1016/j.ajogmf.2020.100159&#x27E9;. &#x27E8;inserm-02924300&#x27E9;",https://www.hal.inserm.fr/inserm-02924300
178,3205856,"Pierre-Marie Duret, Nicolas Meyer, Alain Saraux, Valérie Devauchelle-Pensec, Raphaele Seror, et al.. Seasonal effect on fatigue, pain and dryness in primary Sjögren’s syndrome. Arthritis Research & Therapy, BMC, 2020, 22 (1), pp.39. &#x27E8;10.1186/s13075-020-2118-1&#x27E9;. &#x27E8;hal-03205856&#x27E9;",https://hal.archives-ouvertes.fr/hal-03205856
179,2547911,"Philippe Gautret, Jean-Christophe Lagier, Philippe Parola, van Thuan Hoang, Line Meddeb, et al.. Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study. Travel Medicine and Infectious Disease, Elsevier, 2020, pp.101663. &#x27E8;10.1016/j.tmaid.2020.101663&#x27E9;. &#x27E8;hal-02547911&#x27E9;",https://hal-amu.archives-ouvertes.fr/hal-02547911
180,2563162,"Frédéric Sacher, Laurent Fauchier, Serge Boveda, Christian de Chillou, Pascal Defaye, et al.. Use of drugs with potential cardiac effect in the setting of SARS-CoV-2 infection. Archives of cardiovascular diseases, Elsevier/French Society of Cardiology, 2020, 113 (5), pp.293-296. &#x27E8;10.1016/j.acvd.2020.04.003&#x27E9;. &#x27E8;hal-02563162&#x27E9;",https://hal-univ-rennes1.archives-ouvertes.fr/hal-02563162
181,3233995,"Cédric Lukas, Julia Mary, Michel Debandt, Claire Daien, Jacques Morel, et al.. Predictors of good response to conventional synthetic DMARDs in early seronegative rheumatoid arthritis: data from the ESPOIR cohort. Arthritis Research and Therapy, BioMed Central, 2019, 21, pp.243. &#x27E8;10.1186/s13075-019-2020-x&#x27E9;. &#x27E8;hal-02542646&#x27E9;",https://hal.umontpellier.fr/hal-02542646
182,2944721,"Allan Sauvat, Fabiola Ciccosanti, Francesca Colavita, Martina Rienzo, Concetta Castilletti, et al.. On-target versus off-target effects of drugs inhibiting the replication of SARS-CoV-2. Cell Death and Disease, Nature Publishing Group, 2020, 11 (8), pp.656. &#x27E8;10.1038/s41419-020-02842-x&#x27E9;. &#x27E8;hal-02944721&#x27E9;",https://hal.sorbonne-universite.fr/hal-02944721
183,2882632,"Srinivasa Reddy Bonam, Sylviane Muller, Jagadeesh Bayry, Daniel Klionsky. Autophagy as an emerging target for COVID-19: lessons from an old friend, chloroquine. Autophagy, Taylor & Francis, 2020, &#x27E8;10.1080/15548627.2020.1779467&#x27E9;. &#x27E8;inserm-02882632&#x27E9;",https://www.hal.inserm.fr/inserm-02882632
184,3149258,"M. Million, P. Gautret, P. Colson, Y. Roussel, G. Dubourg, et al.. Clinical efficacy of chloroquine derivatives in COVID-19 infection: comparative meta-analysis between the big data and the real world. NEW MICROBES AND NEW INFECTIONS, 2020, 38, &#x27E8;10.1016/j.nmni.2020.100709&#x27E9;. &#x27E8;hal-03149258&#x27E9;",https://hal-amu.archives-ouvertes.fr/hal-03149258
185,3318617,"Ludovic Trefond, Elodie Drumez, Marc Andre, Nathalie Costedoat-Chalumeau, Raphaèle Seror, et al.. Impact of hydroxychloroquine used as DMARD on SARS-CoV-2 tests and infection evolution in a population of 871 patients with inflammatory rheumatic and musculoskeletal diseases. Joint Bone Spine, Elsevier Masson, 2021, 88 (6), pp.1-4. &#x27E8;10.1016/j.jbspin.2021.105226&#x27E9;. &#x27E8;hal-03318617&#x27E9;",https://hal.inrae.fr/hal-03318617
186,3373990,"Ludovic Trefond, Elodie Drumez, Marc Andre, Nathalie Costedoat-Chalumeau, Raphaèle Seror, et al.. Effet d’un traitement par hydroxychloroquine prescrit comme traitement de fond de rhumatismes inflammatoires chroniques ou maladies auto-immunes systémiques sur les tests diagnostiques et l’évolution de l’infection à SARS CoV-2: étude de 871 patients. Revue du Rhumatisme, Elsevier, 2021, pp.1-11. &#x27E8;10.1016/j.rhum.2021.09.004&#x27E9;. &#x27E8;hal-03373990&#x27E9;",https://hal.inrae.fr/hal-03373990
187,3198120,"Danielle Perez-Bercoff, Hélène Laude, Morgane Lemaire, Oliver Hunewald, Valerie Thiers, et al.. Sustained high expression of multiple APOBEC3 cytidine deaminases in systemic lupus erythematosus. Scientific Reports, Nature Publishing Group, 2021, 11 (1), pp.7893. &#x27E8;10.1038/s41598-021-87024-1&#x27E9;. &#x27E8;hal-03198120&#x27E9;",https://hal.sorbonne-universite.fr/hal-03198120
188,3136068,"Jean Gaudart, Jordi Landier, Laetitia Huiart, Eva Legendre, Laurent Lehot, et al.. Factors associated with the spatial heterogeneity of the first wave of COVID-19 in France: a nationwide geo-epidemiological study. The Lancet Public Health, In press, &#x27E8;10.1016/S2468-2667(21)00006-2&#x27E9;. &#x27E8;hal-03136068&#x27E9;",https://hal.sorbonne-universite.fr/hal-03136068
189,3375439,"Manuel Ramos-Casals, Pilar Brito-Zerón, Stefano Bombardieri, Hendrika Bootsma, Salvatore de Vita, et al.. EULAR recommendations for the management of Sjögren’s syndrome with topical and systemic therapies. Annals of the Rheumatic Diseases, BMJ Publishing Group, 2019, 79 (1), pp.3-18. &#x27E8;10.1136/annrheumdis-2019-216114&#x27E9;. &#x27E8;hal-03375439&#x27E9;",https://hal.umontpellier.fr/hal-03375439
190,2922005,"Florian Lemaitre, Caroline Solas, Matthieu Grégoire, Laurence Lagarce, Laure Elens, et al.. Potential drug-drug interactions associated with drugs currently proposed for COVID-19 treatment in patients receiving other treatments. Fundamental and Clinical Pharmacology, Wiley, 2020, 34 (5), pp.530-547. &#x27E8;10.1111/fcp.12586&#x27E9;. &#x27E8;hal-02888066&#x27E9;",https://hal.archives-ouvertes.fr/hal-02888066
191,2171141,"Laure Gossec, Anna Moltó, Xavier Romand, Déborah Puyraimond-Zemmour, Matthieu Lavielle, et al.. Recommendations for the assessment and optimization of adherence to disease-modifying drugs in chronic inflammatory rheumatic diseases: A process based on literature reviews and expert consensus. Joint Bone Spine, Elsevier Masson, 2019, 86 (1), pp.13-19. &#x27E8;10.1016/j.jbspin.2018.08.006&#x27E9;. &#x27E8;hal-02171141&#x27E9;",https://hal.sorbonne-universite.fr/hal-02171141
192,2171337,"Adrien Mirouse, Raphaele Séror, Eric Vicaut, Xavier Mariette, Maxime Dougados, et al.. Arthritis in primary Sjögren's syndrome: Characteristics, outcome and treatment from French multicenter retrospective study. Autoimmunity Reviews, Elsevier, 2019, 18 (1), pp.9-14. &#x27E8;10.1016/j.autrev.2018.06.015&#x27E9;. &#x27E8;hal-02171337&#x27E9;",https://hal.sorbonne-universite.fr/hal-02171337
193,1788622,"Matthieu Million, Nathalie Bardin, Simon Bessis, Nadia Nouiakh, Charlaine Douliery, et al.. Thrombosis and antiphospholipid antibody syndrome during acute Q fever. Medicine, Lippincott, Williams & Wilkins, 2017, 96 (29), pp.e7578. &#x27E8;10.1097/MD.0000000000007578&#x27E9;. &#x27E8;hal-01758322&#x27E9;",https://hal.archives-ouvertes.fr/hal-01758322
194,2189276,"Marie Jachiet, Béatrice Flageul, Alban Deroux, Alain Le Quellec, François Maurier, et al.. The Clinical Spectrum and Therapeutic Management of Hypocomplementemic Urticarial Vasculitis: Data From a French Nationwide Study of Fifty‐Seven Patients. Arthritis & rheumatology, Wiley, 2015, 67 (2), pp.527-534. &#x27E8;10.1002/art.38956&#x27E9;. &#x27E8;hal-02189276&#x27E9;",https://hal.umontpellier.fr/hal-02189276
195,2936563,"Sophie Caillard, Dany Anglicheau, Marie Matignon, Antoine Dürrbach, Clarisse Greze, et al.. An initial report from the French SOT COVID Registry suggests high mortality due to Covid-19 in recipients of kidney transplants. Kidney International, Nature Publishing Group, 2020, 98 (6), pp.1549-1558. &#x27E8;10.1016/j.kint.2020.08.005&#x27E9;. &#x27E8;hal-02930165&#x27E9;",https://hal.archives-ouvertes.fr/hal-02930165
196,2995875,"van Thu Nguyen, Philippe Riviere, Pierre Ripoll, Julien Barnier, Romain Vuillemot, et al.. Research response to coronavirus disease 2019 needed better coordination and collaboration: a living mapping of registered trials. Journal of Clinical Epidemiology, Elsevier, 2021, 130, pp.107-116. &#x27E8;10.1016/j.jclinepi.2020.10.010&#x27E9;. &#x27E8;hal-02995875&#x27E9;",https://hal.archives-ouvertes.fr/hal-02995875
